Europe – What’s in the Brexit trade deal for the pharmaceutical and medical device industries?

After years of painstaking negotiations, the UK parted ways with the EU on 1 January after an 11-month transition period with a 1,200-plus page trade deal in hand, narrowly avoiding a no-deal scenario.
 
The trade deal, which was reached on 24 December, avoids tariffs and quotas on goods traded between the EU and UK and sets forth some provisions for cooperation and alignment on a range of issues from transportation to environmental protection but avoids major topics such as foreign policy and defense.
 
The deal is currently operating on a provisional basis through 28 February until the European Parliament consents to the agreement and the European Council adopts the decision on the conclusion of the agreement. The agreement was signed by the presidents of the European Council and Commission and approved by the UK Parliament on 30 December…